Allen Wealth Management’s AbbVie ABBV Stock Holding History

Allen Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$283K	Hold	1,125	–	–	0.14%	51
2026 Q1	$245K	Hold	1,125	–	–	0.12%	58
2025 Q4	$257K	Sell	1,125 -184	-14%	-$41.9K	0.15%	56
2025 Q3	$303K	Sell	1,309 -80	-6%	-$16.3K	0.21%	52
2025 Q2	$258K	Sell	1,389 -50	-3%	-$9.29K	0.18%	53
2025 Q1	$301K	Hold	1,439	–	–	0.21%	49
2024 Q4	$256K	Hold	1,439	–	–	0.18%	54
2024 Q3	$284K	Buy	1,439 +200	+16%	+$37.3K	0.2%	53
2024 Q2	$213K	Sell	1,239 -16	-1%	-$2.65K	0.19%	58
2024 Q1	$229K	Buy	+1,255	New	+$216K	0.2%	57

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Allen Wealth Management's ABBV Position: Q2 2026 in Review

Allen Wealth Management held its AbbVie (ABBV) position steady in Q2 2026 at 1,125 shares worth $283K. The position accounts for 0.14% of the portfolio, ranked #51.

Allen Wealth Management first reported a position in ABBV in Q1 2024 and has held it in 10 quarters since. The position peaked at $303K in Q3 2025. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Allen Wealth Management held 1,125 shares of AbbVie worth $283K as of Q2 2026.
Allen Wealth Management left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.14% of Allen Wealth Management's portfolio in Q2 2026, its #51 holding.
Allen Wealth Management first reported a position in AbbVie in Q1 2024 and has held it in 10 quarters since.
Allen Wealth Management's AbbVie position peaked at $303K in Q3 2025.
2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Allen Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.